Shorter assessment periods don't provide reliable data on whether the higher concentration truly improves outcomes
Available at: Camillo L et al
One study established a cortical synucleinopathy model by overexpressing human -syn in the mouse primary motor cortex (M1)
Abnormal sperm morphology and an increase in malondialdehyde (MDA) levels were observed in the 10 mg/kg treatment group, whereas the changes were more pronounced in the 20 mg/kg treatment group, which exhibited a decrease in sperm counts, abnormal sperm morphology, DNA damage, degradation of cellular tubular structures, and elevated serum LH and testosterone levels
Glutathione is not an approved skin-whitening drug, and any IV plan should be a careful clinical decision, not a cosmetic promise
Let's explore the key considerations: Individual Factors: The time it takes for glutathione to show results can vary from person to person